ArticleClinicoEconomics and outcomes research : CEOR2023

Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland.

Taru Hallinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.